Anson Funds Management LP

Holdings History for ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

Symbol: ONCY on Nasdaq
Investment type: Equity / Common Stock, no par value
Latest Disclosed Shares Owned: 7,649,050 shares
Security Ownership %: 7%

Shares, Excluding Options vs Price

Value, Excluding Options

Anson Funds Management LP ownership in ONCOLYTICS BIOTECH INC Common Stock, no par value (ONCY)

14 Nov 2025 - Anson Funds Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,649,050 shares of ONCOLYTICS BIOTECH INC Common Stock, no par value (ONCY). This represents 7% ownership of the company. In their previous filing dated 14 Feb 2025, Anson Funds Management LP had reported owning 8,185,743 shares, indicating a decrease of +6.6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Anson Funds Management LP	7%	-26%	$10,708,670	7,649,050	-536,693	-6.6%	$1.40	13G/A	30 Sep 2025	14 Nov 2025, 15:05
Anson Funds Management LP	9.6%		$4,584,016	8,185,743			$0.56	13G	31 Dec 2024	14 Feb 2025, 18:30

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2024		-1.1%	$0	0	-3,814,299	-100%	$0.83	Q1 2024
31 Dec 2023	1.1%	-0.42%	$5,149,304	3,814,299	-1,487,737	-28%	$1.35	Q4 2023
30 Sep 2023	3.8%	+3.8%	$11,558,438	5,302,036	+5,302,036	NEW	$2.18	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.